Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222

Molecular Therapy

Volumn 23, Issue 12, 2015, Pages 1899-1911

  Zhao, Xihe ^a   Wang, Ping ^a   Liu, Jing ^a   Zheng, Jian ^a   Liu, Yunhui ^a   Chen, Jiajia ^a   Xue, Yixue ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COFILIN; MICRORNA 222; PROTEIN BAX; PROTEIN BCL 2; BAX PROTEIN, HUMAN; BMF PROTEIN, HUMAN; GAS5 LONG NON-CODING RNA, HUMAN; LONG UNTRANSLATED RNA; MICRORNA; MIRN222 MICRORNA, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VESPR SEMAPHORIN RECEPTOR; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BCL 2 MODIFYING FACTOR GENE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GLIOBLASTOMA CELL LINE; GLIOMA; GLIOMA CELL; GROWTH ARREST SPECIFIC 5 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PLEXIN C1 GENE; SURVIVAL RATE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; UPREGULATION; ANIMAL; CELL MOTION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC THERAPY; GLIOMA; HUMANS; MICE; MICE, NUDE; MICRORNAS; RECEPTORS, VIRUS; RNA, LONG NONCODING; TRANSFECTION; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84952636520     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2015.170     Document Type: Article

References (47)

1. Furnari, FB, Fenton, T, Bachoo, RM, Mukasa, A, Stommel, JM, Stegh, A et al. (2007). Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710.
2. Wang, Y, Wang, Y, Li, J, Zhang, Y, Yin, H, and Han, B (2015). CRNDE, a longnoncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer letters.
3. Wang, P, Liu, YH, Yao, YL, Li, Z, Li, ZQ, Ma, J et al. (2015). Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cell Signal 27: 275-282.
4. Zhou, X, Ren, Y, Zhang, J, Zhang, C, Zhang, K, Han, L et al. (2015). HOTAIR is a therapeutic target in glioblastoma. Oncotarget 6: 8353-8365.
5. Nam, RK, Zhang, WW, Loblaw, DA, Klotz, LH, Trachtenberg, J, Jewett, MA et al. (2008). A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer. Prostate Cancer Prostatic Dis 11: 241-246.
6. Smith, CM and Steitz, JA (1998). Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol Cell Biol 18: 6897-6909.
7. Schneider, C, King, RM and Philipson, L (1988). Genes specifically expressed at growth arrest of mammalian cells. Cell 54: 787-793.
8. Pickard, MR and Williams, GT (2014). Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy. Breast Cancer Res Treat 145: 359-370.
9. Pickard, MR, Mourtada-Maarabouni, M and Williams, GT (2013). Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim Biophys Acta 1832: 1613-1623.
10. Mourtada-Maarabouni, M, Hedge, VL, Kirkham, L, Farzaneh, F and Williams, GT (2008). Growth arrest in human T-cells is controlled by the non-coding RNA growtharrest-specific transcript 5 (GAS5). J Cell Sci 121(Pt 7): 939-946.
11. Gee, HE, Buffa, FM, Camps, C, Ramachandran, A, Leek, R, Taylor, M et al. (2011). The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer 104: 1168-1177.
12. Visani, M, de Biase, D, Marucci, G, Taccioli, C, Baruzzi, A, Pession, A, et al. (2013). Definition of miRNAs expression profile in glioblastoma samples: the relevance of nonneoplastic brain reference. PloS one 8: e55314.
13. Quintavalle, C, Garofalo, M, Zanca, C, Romano, G, Iaboni, M, del Basso De Caro, M et al. (2012). miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTP. Oncogene 31: 858-868.
14. le Sage, C, Nagel, R, Egan, DA, Schrier, M, Mesman, E, Mangiola, A et al. (2007). Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26: 3699-3708.
15. Ueda, R, Kohanbash, G, Sasaki, K, Fujita, M, Zhu, X, Kastenhuber, ER et al. (2009). Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. Proc Natl Acad Sci USA 106: 10746-10751.
16. Labi, V, Erlacher, M, Kiessling, S, Manzl, C, Frenzel, A, O'Reilly, L et al. (2008). Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma development. J Exp Med 205: 641-655.
17. Puthalakath, H, Villunger, A, O'Reilly, LA, Beaumont, JG, Coultas, L, Cheney, RE et al. (2001). Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 293: 1829-1832.
18. Bouillet, P and Strasser, A (2002). BH3-only proteins-evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci 115(Pt 8): 1567-1574.
19. Lappalainen, P and Drubin, DG (1997). Cofilin promotes rapid actin filament turnover in vivo. Nature 388: 78-82.
20. Arber, S, Barbayannis, FA, Hanser, H, Schneider, C, Stanyon, CA, Bernard, O et al. (1998). Regulation of actin dynamics through phosphorylation of cofilin by LIMkinase. Nature 393: 805-809.
21. Cesana, M, Cacchiarelli, D, Legnini, I, Santini, T, Sthandier, O, Chinappi, M et al. (2011). A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147: 358-369.
22. Medina, R, Zaidi, SK, Liu, CG, Stein, JL, van Wijnen, AJ, Croce, CM et al. (2008). MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res 68: 2773-2780.
23. Visani, M, de Biase, D, Marucci, G, Cerasoli, S, Nigrisoli, E, Bacchi Reggiani, ML et al.; PERNO study group. (2014). Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. Mol Oncol 8: 417-430.
24. Hitomi, J, Christofferson, DE, Ng, A, Yao, J, Degterev, A, Xavier, RJ et al. (2008). Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135: 1311-1323.
25. Delgado, M and Tesfaigzi, Y (2014). Is BMF central for anoikis and autophagy Autophagy 10: 168-169.
26. Gerecova, G, Kopanicova, J, Jaka, P, Bhalova, L, Juhasova, B, Bhatia-Kiššova, I et al. (2013). BH3-only proteins Noxa, Bik, Bmf, and Bid activate Bax and Bak indirectly when studied in yeast model. FEMS Yeast Res 13: 747-754.
27. Scott, GA, McClelland, LA, Fricke, AF and Fender, A (2009). Plexin C1, a receptor for semaphorin 7a, inactivates cofilin and is a potential tumor suppressor for melanoma progression. J Invest Dermatol 129: 954-963.
28. Jones, C and Baker, SJ (2014). Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat Rev Cancer 14:.
29. Brandsma, D, Stalpers, L, Taal, W, Sminia, P and van den Bent, MJ (2008). Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9: 453-461.
30. Zhang, JX, Han, L, Bao, ZS, Wang, YY, Chen, LY, Yan, W et al.; Chinese Glioma Cooperative Group. (2013). HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol 15: 1595-1603.
31. Renganathan, A, Kresoja-Rakic, J, Echeverry, N, Ziltener, G, Vrugt, B, Opitz, I et al. (2014). GAS5 long non-coding RNA in malignant pleural mesothelioma. Mol Cancer 13: 119.
32. Ling, H, Vincent, K, Pichler, M, Fodde, R, Berindan-Neagoe, I, Slack, FJ, et al. (2015). Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene.
33. Liu, N and Pan, T (2015). RNA epigenetics. Transl Res 165: 28-35.
34. Rao, X, Di Leva, G, Li, M, Fang, F, Devlin, C, Hartman-Frey, C et al. (2011). MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 30: 1082-1097.
35. Zhou, M, Liu, Z, Zhao, Y, Ding, Y, Liu, H, Xi, Y et al. (2010). MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem 285: 21496-21507.
36. Sun, T, Wang, Q, Balk, S, Brown, M, Lee, GS and Kantoff, P (2009). The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res 69: 3356-3363.
37. Zhang, C, Zhang, J, Hao, J, Shi, Z, Wang, Y, Han, L et al. (2012). High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma. J Transl Med 10: 119.
38. Quintavalle, C, Mangani, D, Roscigno, G, Romano, G, Diaz-Lagares, A, Iaboni, M et al. (2013). MiR-221/222 target the DNA methyltransferase MGMT in glioma cells. PLoS One 8: e74466.
39. Cartron, PF, Loussouarn, D, Campone, M, Martin, SA and Vallette, FM (2012). Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiforme. Cell Death Dis 3: e421.
40. Fiori, ME, Barbini, C, Haas, TL, Marroncelli, N, Patrizii, M, Biffoni, M et al. (2014). Antitumor effect of miR-197 targeting in p53 wild-type lung cancer. Cell Death Differ 21: 774-782.
41. Catuogno, S, Cerchia, L, Romano, G, Pognonec, P, Condorelli, G and de Franciscis, V (2013). miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis. Oncogene 32: 341-351.
42. Kutuk, O and Letai, A (2010). Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells. Cell Death Differ 17: 1624-1635.
43. Hinds, MG, Smits, C, Fredericks-Short, R, Risk, JM, Bailey, M, Huang, DC et al. (2007). Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets. Cell Death Differ 14: 128-136.
44. Shimizu, S, Narita, M and Tsujimoto, Y (1999). Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483-487.
45. Chen, Y, Soong, J, Mohanty, S, Xu, L and Scott, G (2013). The neural guidance receptor Plexin C1 delays melanoma progression. Oncogene 32: 4941-4949.
46. Uesugi, K, Oinuma, I, Katoh, H and Negishi, M (2009). Different requirement for Rnd GTPases of R-Ras GAP activity of Plexin-C1 and Plexin-D1. J Biol Chem 284: 6743-6751.
47. Chen, Y, Soong, J, Mohanty, S, Xu, L and Scott, G (2013). The neural guidance receptor Plexin C1 delays melanoma progression. Oncogene 32: 4941-4949.